These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 29031072)

  • 21. Glial reactions in Parkinson's disease.
    McGeer PL; McGeer EG
    Mov Disord; 2008 Mar; 23(4):474-83. PubMed ID: 18044695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of natural products in the discovery of new drug candidates for the treatment of neurodegenerative disorders I: Parkinson's disease.
    Campos HC; da Rocha MD; Viegas FP; Nicastro PC; Fossaluzza PC; Fraga CA; Barreiro EJ; Viegas C
    CNS Neurol Disord Drug Targets; 2011 Mar; 10(2):239-50. PubMed ID: 20874702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A focus on natural products for preventing and cure of mitochondrial dysfunction in Parkinson's disease.
    Mohammadipour A
    Metab Brain Dis; 2022 Apr; 37(4):889-900. PubMed ID: 35156154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
    Hattori N
    Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Strategies for target identification of antimicrobial natural products.
    Farha MA; Brown ED
    Nat Prod Rep; 2016 May; 33(5):668-80. PubMed ID: 26806527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phytochemicals as future drugs for Parkinson's disease: a comprehensive review.
    Shahpiri Z; Bahramsoltani R; Hosein Farzaei M; Farzaei F; Rahimi R
    Rev Neurosci; 2016 Aug; 27(6):651-68. PubMed ID: 27124673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Important medicinal herbs in Parkinson's disease pharmacotherapy.
    Srivastav S; Fatima M; Mondal AC
    Biomed Pharmacother; 2017 Aug; 92():856-863. PubMed ID: 28599249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natural product-based amyloid inhibitors.
    Velander P; Wu L; Henderson F; Zhang S; Bevan DR; Xu B
    Biochem Pharmacol; 2017 Sep; 139():40-55. PubMed ID: 28390938
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Grand Challenge. 2. Phenotypic Profiling of a Natural Product Library on Parkinson's Patient-Derived Cells.
    Vial ML; Zencak D; Grkovic T; Gorse AD; Mackay-Sim A; Mellick GD; Wood SA; Quinn RJ
    J Nat Prod; 2016 Aug; 79(8):1982-9. PubMed ID: 27447544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Recent Look into Natural Products that have Potential to Inhibit Cholinesterases and Monoamine Oxidase B: Update for 2010-2019.
    Gulcan HO; Orhan IE
    Comb Chem High Throughput Screen; 2020; 23(9):862-876. PubMed ID: 31985374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural products from aquatic eukaryotic microorganisms for cancer therapy: Perspectives on anti-tumour properties of ciliate bioactive molecules.
    Catalani E; Proietti Serafini F; Zecchini S; Picchietti S; Fausto AM; Marcantoni E; Buonanno F; Ortenzi C; Perrotta C; Cervia D
    Pharmacol Res; 2016 Nov; 113(Pt A):409-420. PubMed ID: 27650755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analgesic substances derived from natural products (natureceuticals).
    McCurdy CR; Scully SS
    Life Sci; 2005 Dec; 78(5):476-84. PubMed ID: 16216276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of potential drugs for Parkinson's disease based on a sub-pathway method.
    Sun AG; Lin AQ; Huang SY; Huo D; Cong CH
    Int J Neurosci; 2016; 126(4):318-25. PubMed ID: 25405535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bioactive Natural Products Prioritization Using Massive Multi-informational Molecular Networks.
    Olivon F; Allard PM; Koval A; Righi D; Genta-Jouve G; Neyts J; Apel C; Pannecouque C; Nothias LF; Cachet X; Marcourt L; Roussi F; Katanaev VL; Touboul D; Wolfender JL; Litaudon M
    ACS Chem Biol; 2017 Oct; 12(10):2644-2651. PubMed ID: 28829118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of natural anti-inflammatory alkaloids: Potential leads for the drug discovery for the treatment of inflammation.
    Bai R; Yao C; Zhong Z; Ge J; Bai Z; Ye X; Xie T; Xie Y
    Eur J Med Chem; 2021 Mar; 213():113165. PubMed ID: 33454546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parkinson's disease and enhanced inflammatory response.
    Stojkovska I; Wagner BM; Morrison BE
    Exp Biol Med (Maywood); 2015 Nov; 240(11):1387-95. PubMed ID: 25769314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular approaches towards development of purified natural products and their structurally known derivatives as efficient anti-cancer drugs: current trends.
    Saha SK; Khuda-Bukhsh AR
    Eur J Pharmacol; 2013 Aug; 714(1-3):239-48. PubMed ID: 23819913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epigenetic targeting of histone deacetylase: therapeutic potential in Parkinson's disease?
    Harrison IF; Dexter DT
    Pharmacol Ther; 2013 Oct; 140(1):34-52. PubMed ID: 23711791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rational drug discovery design approaches for treating Parkinson's disease.
    Van der Schyf CJ
    Expert Opin Drug Discov; 2015 Jul; 10(7):713-41. PubMed ID: 26054694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insights into Neuroinflammation in Parkinson's Disease: From Biomarkers to Anti-Inflammatory Based Therapies.
    Rocha NP; de Miranda AS; Teixeira AL
    Biomed Res Int; 2015; 2015():628192. PubMed ID: 26295044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.